Teva Allowed New Mifepristone Claim But Not New Defendant
By Bryan Koenig · January 28, 2026, 8:08 PM EST
A California federal judge gave Teva permission to update its antitrust suit accusing Corcept Therapeutics of using patent system abuse, bribes and exclusive dealing to block generic competition to its cortisol...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login